{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:14:44Z","timestamp":1789751684454,"version":"4.0.1"},"reference-count":34,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.205368","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T19:37:34Z","timestamp":1704397054000},"source":"Crossref","is-referenced-by-count":3,"title":["MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer"],"prefix":"10.18632","author":[{"given":"Zhi-Wen","family":"Wang","sequence":"first","affiliation":[{"name":"Institute of Biology and Medicine, College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan 430081, Hubei, P.R. China"},{"name":"Key Laboratory of Chronic Noncommunicable Diseases, Yueyang Vocational Technical College, Yueyang 414006, Hunan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Ying","family":"Yu","sequence":"additional","affiliation":[{"name":"Central Laboratory, Tumor Hospital Affiliated to Nantong University, Nantong 226361, Jiangsu, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jiao","family":"Xu","sequence":"additional","affiliation":[{"name":"Zhaoyuan Linglong Central Health Center, Zhaoyuan 265400, Shandong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Yi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Yueyang People\u2019s Hospital, Yueyang Hospital Affiliated to Hunan Normal University Neoplasm Ward 1, Yueyang 414000, Hunan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Peng","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Biology and Medicine, College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan 430081, Hubei, P.R. China"},{"name":"College of Science, Wuhan University of Science and Technology, Wuhan 430081, Hubei, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Hua","family":"Liao","sequence":"additional","affiliation":[{"name":"Institute of Biology and Medicine, College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan 430081, Hubei, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"151875","DOI":"10.1016\/j.imbio.2019.11.010","article-title":"Promising approaches in cancer immunotherapy.","volume":"22","author":"Taefehshokr","year":"2020","journal-title":"Immunobiology"},{"key":"2","doi-asserted-by":"publisher","first-page":"8496","DOI":"10.1016\/j.vaccine.2011.09.014","article-title":"MAGE-A family: attractive targets for cancer immunotherapy.","volume":"2","author":"Shan","year":"2011","journal-title":"Vaccine"},{"key":"3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3389\/fimmu.2018.00947","article-title":"NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.","volume":"9","author":"Decock","year":"2018","journal-title":"Front Immunol"},{"key":"4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4161\/cbt.12.3.15949","article-title":"Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: identification of specific tumor marker and potential targets for immunotherapy.","volume":"1","author":"Abbaszadegan","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"5","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/ijc.20953","article-title":"NY-ESO-1\/LAGE-1 coexpression with MAGE-A cancer\/testis antigens: a tissue microarray study.","volume":"11","author":"Tornillo","year":"2005","journal-title":"Int J Cancer"},{"key":"6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00432-019-02840-3","article-title":"Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy.","volume":"14","author":"Zhang","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2012.05.011","article-title":"MAGE-A antigens as targets in tumour therapy.","volume":"32","author":"Marcar","year":"2012","journal-title":"Cancer Lett"},{"key":"8","doi-asserted-by":"publisher","first-page":"e1009589","DOI":"10.1371\/journal.pgen.1009589","article-title":"Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.","volume":"1","author":"Schwartz","year":"2021","journal-title":"PLoS Genet"},{"key":"9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.arcmed.2013.10.005","article-title":"Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism.","volume":"4","author":"Shan","year":"2014","journal-title":"Arch Med Res"},{"key":"10","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/ijc.27914","article-title":"MAGE-A10 cancer\/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas.","volume":"13","author":"Hudolin","year":"2013","journal-title":"Int J Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1002\/ijc.22282","article-title":"MAGE-A9 mRNA and protein expression in bladder cancer.","volume":"12","author":"Fradet","year":"2007","journal-title":"Int J Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1158\/2326-6066.CIR-13-0211","article-title":"Assessment of MAGE-A expression in resected non-small cell lung cancer in relation to clinicopathologic features and mutational status of EGFR and KRAS.","volume":"2","author":"Valmori","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"4","author":"Smyth","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/psp.2013.56","article-title":"Application of ggplot2 to Pharmacometric Graphics.","volume":"2","author":"Murphy","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/c5mb00663e","article-title":"ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization.","volume":"1","author":"He","year":"2016","journal-title":"Mol Biosyst"},{"key":"16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"1","author":"He","year":"2012","journal-title":"OMICS"},{"key":"17","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","article-title":"DOSE: an R\/Bioconductor package for disease ontology semantic and enrichment analysis.","volume":"3","author":"He","year":"2015","journal-title":"Bioinformatics"},{"key":"18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling Tumor Infiltrating Immune Cells with CIBERSORT.","volume":"171","author":"Alizadeh","year":"2018","journal-title":"Methods Mol Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"607742","DOI":"10.3389\/fonc.2020.607742","article-title":"Re-Clustering and Profiling of Digestive System Tumors According to Microenvironment Components.","volume":"1","author":"Gao","year":"2021","journal-title":"Front Oncol"},{"key":"20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"7","author":"Bray","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"21","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.prp.2017.05.007","article-title":"MAGE-A family is involved in gastric cancer progression and indicates poor prognosis of gastric cancer patients.","volume":"21","author":"Shan","year":"2017","journal-title":"Pathol Res Pract"},{"key":"22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2217\/1750743X.1.1.19","article-title":"MAGE A3 antigen-specific cancer immunotherapeutic.","volume":"1","author":"Bunn","year":"2009","journal-title":"Immunotherapy"},{"key":"23","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1097\/JTO.0000000000000653","article-title":"Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer.","volume":"1","author":"Jarnjak","year":"2015","journal-title":"J Thorac Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1200\/JCO.2012.43.7103","article-title":"Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results.","volume":"3","author":"Basko","year":"2013","journal-title":"J Clin Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"107889","DOI":"10.1016\/j.intimp.2021.107889","article-title":"A novel era of cancer\/testis antigen in cancer immunotherapy.","volume":"9","author":"He","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"26","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1038\/onc.2017.131","article-title":"MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.","volume":"3","author":"Sang","year":"2017","journal-title":"Oncogene"},{"key":"27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4149\/neo_2018_170625N440","article-title":"Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.","volume":"6","author":"Yan","year":"2018","journal-title":"Neoplasma"},{"key":"28","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3892\/ijo.2017.3984","article-title":"Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.","volume":"5","author":"Yasufuku","year":"2017","journal-title":"Int J Oncol"},{"key":"29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00432-021-03859-1","article-title":"Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression.","volume":"14","author":"Mohsenzadegan","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s13402-015-0261-5","article-title":"Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.","volume":"3","author":"Tan","year":"2016","journal-title":"Cell Oncol (Dordr)"},{"key":"31","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00784-017-2242-8","article-title":"MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer.","volume":"2","author":"M\u00fcller-Richter","year":"2018","journal-title":"Clin Oral Investig"},{"key":"32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.arcmed.2016.06.001","article-title":"Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA Microarray.","volume":"4","author":"Shan","year":"2016","journal-title":"Arch Med Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"24809","DOI":"10.1074\/jbc.M113.468579","article-title":"Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.","volume":"28","author":"Wilson","year":"2013","journal-title":"J Biol Chem"},{"key":"34","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2147\/CMAR.S237867","article-title":"MAGE-A11 Expression Predicts Patient Prognosis in Head and Neck Squamous Cell Carcinoma.","volume":"1","author":"Dai","year":"2020","journal-title":"Cancer Manag Res"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T19:37:36Z","timestamp":1704397056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":34,"alternative-id":["205368"],"URL":"https:\/\/doi.org\/10.18632\/aging.205368","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]}}}